Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROKIDNEY CORP. Director's Dealing 2022

Sep 1, 2022

32485_dirs_2022-09-01_1fcfcf31-8c49-4940-84d9-48bc0b0b105f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2022-08-30

Reporting Person: Cowen Aaron (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-08-30 Class A Ordinary Shares P 706 $7.49 Acquired 6270006 Indirect
2022-08-31 Class A Ordinary Shares P 1062 $8.93 Acquired 6271068 Indirect
2022-08-31 Class A Ordinary Shares P 2100 $8.94 Acquired 6273168 Indirect

Footnotes

F1: See Exhibit 99.1

F2: See Exhibit 99.1

F3: See Exhibit 99.1

F4: See Exhibit 99.1

F5: See Exhibit 99.1